Ignite Creation Date:
2025-12-24 @ 5:06 PM
Ignite Modification Date:
2026-04-22 @ 1:41 AM
Study NCT ID:
NCT05178550
Status:
COMPLETED
Last Update Posted:
2023-05-22
First Post:
2021-12-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study in Healthy Participants Investigating Biomarkers After Exposure to Heparin When Heparin is Administered in the Fasted State or After a High-fat Meal. Heparin, a Registered Drug, is an Anticoagulant (Blood Thinner) That Prevents the Formation of Blood Clots.
Sponsor:
Novo Nordisk A/S
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
NN6633-4955
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None